podcast | pharmaphorum

Friday 5 December 2025

podcast

Oncology

pharmaphorum podcast Episode 198a - Eric Matthews

Advancing the frontiers of cancer diagnostics: Post-ASCO wit...

Post-ASCO 2025, Eric Matthews, chief business officer at Caris Life Sciences, discusses advancing the frontier of cancer diagnostics and treatment.

Sales & Marketing

pharmaphorum podcast Episode 197a, Florian Schnappauf

Compliance baked into the design core: On AI in life science...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Florian Schnappauf, VP, enterprise commercial strategy Europe, at Veeva Systems.

Oncology

pharmaphorum podcast Episode 196a, Dr Corina Dutcus

Putting patients and their families first: Dr Corina Dutcus,...

Dr Corina Dutcus, senior vice president and oncology global clinical development lead at Eisai, discusses the data Eisai presented at ASCO 2025.

Oncology

pharmaphorum podcast Episode 195a - Dan Schmitt, Actuate

Enhancing anti-tumour activity: A post-ASCO conversation wit...

Market Access

happy man listening to podcast

Why Datavant bought Aetion, and what comes next, with Arnaub...

Digital

pharmaphorum podcast Episode 193a, Pamela Tenaerts, Medable

Post-ASCO 25: Pamela Tenaerts on CGTs and digital-first long...

In a post-ASCO 2025 conversation, pharmaphorum web editor Nicole Raleigh spoke with Dr Pamela Tenaerts, chief medical officer at Medable.